Modified Strategies for Invasive Management of Acute Coronary Syndrome during the COVID-19 Pandemic
Open Access
- 24 December 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (1) , 24
Abstract
The COVID-19 pandemic presents several challenges for managing patients with acute coronary syndrome (ACS). Modified treatment algorithms have been proposed for the pandemic. We assessed new algorithms proposed by The European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Acute Cardiovascular Care Association (ACCA) on patients with ACS admitted to the hospital during the COVID-19 pandemic. The COVID-19 period group (CPG) consisted of patients admitted into a high-volume centre in Prague between 1 February 2020 and 30 May 2020 (n = 181). The reference group (RG) included patients who had been admitted between 1 October 2018 and 31 January 2020 (n = 834). The proportions of patients with different types of ACS admitted before and during the pandemic did not differ significantly: in all ACS patients, KILLIP III-IV class was present in 13.9% in RG and in 9.4% of patients in CPG (p = 0.082). In NSTE-ACS patients, the ejection fraction was lower in the CPG than in the RG (44.7% vs. 50.7%, respectively; p < 0.001). The time from symptom onset to first medical contact did not differ between CPG and RG patients in the respective NSTE-ACS and STEMI groups. The time to early invasive treatment in NSTE-ACS patients and the time to reperfusion in STEMI patients were not significantly different between the RG and the CPG. In-hospital mortality did not differ between the groups in NSTE-ACS patients (odds ratio in the CPG 0.853, 95% confidence interval (CI) 0.247 to 2.951; p = 0.960) nor in STEMI patients (odds ratio in CPG 1.248, 95% CI 0.566 to 2.749; p = 0.735). Modified treatment strategies for ACS during the COVID-19 pandemic did not cause treatment delays. Hospital mortality did not differ.Keywords
Funding Information
- Univerzita Karlova v Praze (UNCE MED 02, PROGRES Q38)
- EU grant (OPVVV) (CZ.02.1.01/0.0/0.0/16_026/0008388)
This publication has 21 references indexed in Scilit:
- Critical Organizational Issues for Cardiologists in the COVID-19 OutbreakCirculation, 2020
- Incidence, Mortality, and Outcome-Predictors of Sudden Cardiac Arrest Complicating Myocardial Infarction Prior to Hospital AdmissionCirculation: Cardiovascular Interventions, 2019
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevationEuropean Heart Journal, 2017
- Incidence, treatment strategies and outcomes of acute coronary syndrome with and without ongoing myocardial ischaemia: results from the CZECH-3 registryEuropean Heart Journal: Acute Cardiovascular Care, 2017
- Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registriesEuropean Heart Journal - Cardiovascular Pharmacotherapy, 2016
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationEuropean Heart Journal, 2015
- The incidence and outcomes of acute coronary syndromes in a central European country: Results of the CZECH-2 registryInternational Journal of Cardiology, 2014
- Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UKThe Lancet, 2014
- German nationwide data on current trends and management of acute myocardial infarction: discrepancies between trials and real-lifeEuropean Heart Journal, 2014
- The incidence, treatment strategies and outcomes of acute coronary syndromes in the “reperfusion network” of different hospital types in the Czech Republic: Results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registryInternational Journal of Cardiology, 2007